Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators.
| Date | Est. | Actual | |
|---|---|---|---|
| Feb 27, 2024 | -$0.30 | -$0.34 | Miss |
| Nov 8, 2023 | -$0.30 | -$0.10 | Beat |
| Aug 8, 2023 | -$0.37 | -$0.30 | Beat |
| May 9, 2023 | -$0.41 | -$0.37 | Beat |
| Feb 28, 2023 | -$0.55 | -$0.34 | Beat |
| Nov 8, 2022 | -$0.59 | -$0.42 | Beat |